George A. Steiner

George A. Steiner's AcademicInfluence.com Rankings

George A. Steiner

Philosophy

#8124

World Rank

#11447

Historical Rank

Logic

#5156

World Rank

#6531

Historical Rank

philosophy Degrees

George A. Steiner

Biology

#10968

World Rank

#14334

Historical Rank

Biochemistry

#1782

World Rank

#1918

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

George A. Steiner's Degrees

Doctorate Medicine Harvard University

Why Is George A. Steiner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

George A. Steiner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. (1978) (553)
Postprandial lipoproteins and progression of coronary atherosclerosis. (1994) (521)
Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. (1995) (519)
Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. (2003) (398)
Effects of Acute Hyperinsulinemia on VLDL Triglyceride and VLDL ApoB Production in Normal Weight and Obese Individuals (1993) (339)
Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease: The Diabetes Atherosclerosis Intervention Study (DAIS) (2003) (291)
Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. (1993) (250)
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS). (2005) (243)
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. (1999) (230)
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. (2002) (224)
Detection of silent myocardial ischemia in diabetes mellitus. (1991) (211)
Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E. (1997) (184)
Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. (2009) (165)
Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity. (2004) (162)
Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia. (1975) (160)
The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. (1987) (158)
Diabetes and Atherosclerosis: an Overview (1981) (150)
Safety and tolerability of dalcetrapib. (2009) (141)
Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis. (1976) (140)
Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. (1993) (137)
Activation of coagulation factor VII during alimentary lipemia. (1994) (137)
Origin of triacylglycerol moiety of plasma very low density lipoproteins in the rat: structural studies. (1995) (130)
Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. (2000) (129)
Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl. (1996) (124)
Hyperlipidemia after renal transplantation: natural history and pathophysiology. (1979) (122)
The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization (1996) (111)
HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age. (1993) (106)
Nutritional assessment of the hospitalized patient. (1988) (104)
Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. (1996) (102)
Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. (1984) (100)
Resistance to Insulin but Not to Glucagon in Lean Human Hypertriglyceridemics (1980) (96)
The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles. (1997) (96)
Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential. (1982) (93)
Atherosclerosis, the major complication of diabetes. (1985) (92)
Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia. (1978) (88)
Influence of heparin on serum free thyroxine. (1969) (87)
Isolation and identification of glycated aminophospholipids from red cells and plasma of diabetic blood (1996) (82)
The effects of prolonged fasting on plasma triglyceride kinetics in man. (1977) (81)
Triglyceride kinetics: effects of dietary glucose, sucrose, or fructose alone or with hyperinsulinemia. (1986) (81)
Progression of Atherosclerosis Is Associated With Variation in the &agr;1-Antitrypsin Gene (2003) (77)
Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels. (1999) (73)
ADIPOSE TISSUE PHYSIOLOGY * (1963) (72)
Contribution of de novo fatty acid synthesis to very low density lipoprotein triacylglycerols: evidence from mass isotopomer distribution analysis of fatty acids synthesized from [2H6]ethanol. (1996) (69)
Improved method for quantitation of B apoprotein in plasma lipoproteins by electroimmunoassay. (1981) (67)
Lipid intervention trials in diabetes. (2000) (67)
Dyslipoproteinemias in diabetes. (1994) (66)
Two sympathetic nerve supplies to brown adipose tissue of the rat. (1969) (65)
Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia. (2004) (63)
Heterogeneity of primary lipoprotein lipase deficiency. (1980) (58)
Postprandial remnant-like lipoproteins in hypertriglyceridemia. (2001) (58)
Turnover and recycling of glucose in man during prolonged fasting. (1977) (58)
BROWN AND WHITE ADIPOSE TISSUE METABOLISM IN COLD-EXPOSED RATS. (1964) (56)
Impaired very low-density lipoprotein-triglyceride catabolism in acute and chronic fructose-fed rats. (1989) (55)
Apolipoprotein B-48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins. (1998) (54)
The metabolic heterogeneity of human very low density lipoprotein triglyceride. (1977) (52)
Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus. (2004) (52)
Receptor and postreceptor insulin resistance induced by in vivo hyperinsulinemia. (1983) (50)
Roles of Lipoprotein Lipase and Hepatic Triglyceride Lipase in the Catabolism In Vivo of Triglyceride‐Rich Lipoproteins (1982) (50)
Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications. (1986) (50)
Triglyceride-rich lipoproteins and atherosclerosis, from fast to feast. (1993) (49)
The independent synthesis of intermediate density lipoproteins in type III hyperlipoproteinemia. (1982) (49)
Partial characterization of the fructose-induced defect in very-low-density lipoprotein triglyceride metabolism. (1991) (47)
Production of Chylomicron-like Lipoproteins from Endogenous Lipid by the Intestine and Liver of Diabetic Dogs (1975) (46)
Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes. (2004) (45)
Alterations in endothelial F-actin microfilaments in rabbit aorta in hypercholesterolemia. (1998) (45)
Apolipoprotein B-48. (1996) (44)
A stable isotope method using a [(2)H(5)]glycerol bolus to measure very low density lipoprotein triglyceride kinetics in humans. (1999) (44)
Laboratory standardization of a large international clinical trial: the DAIS experience. DAIS Project Group. Diabetes Atherosclerosis Intervention Study. (2000) (42)
In vivo regulation of phenylalanine hydroxylation to tyrosine, studied using enrichment in apoB-100. (2008) (42)
The chromogenicity and quantitation of apoB-100 and apoB-48 of human plasma lipoproteins on analytical SDS gel electrophoresis. (1987) (41)
VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin. (1994) (41)
Relative Contribution of Triglyceride‐Rich Lipoprotein Particle Size and Number to Plasma Triglyceride Concentration (1985) (41)
Dialysis hyperlipemia: response to dietary manipulations. (1980) (40)
Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats. (1997) (40)
Hyperinsulinemia and Triglyceride-Rich Lipoproteins (1996) (39)
Obesity and Lipoprotein Metabolism (1983) (36)
Familial aggregation of diabetes and hypertension in a case-control study of colorectal neoplasia. (2002) (36)
Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes. (2002) (35)
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study (2001) (33)
Synthesis of VLDL by isolated rat hepatocytes in suspension. (1975) (32)
Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities. (1999) (32)
Multiple symmetric lipomatosis (Launois-Bensaude syndrome) - adipose tissue insensitivity to cyclic AMP. (1979) (31)
Treating lipid abnormalities in patients with type 2 diabetes mellitus. (2001) (31)
Milk and plasma lipid composition in a lactating patient with type I hyperlipoproteinemia. (1985) (31)
Portal v peripheral hyperinsulinemia and very low density lipoprotein triglyceride kinetics. (1986) (30)
Fibrates and coronary risk reduction. (2005) (29)
Fibrates in the metabolic syndrome and in diabetes. (2004) (28)
Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population. (1980) (28)
Changes in very low density lipoprotein particle size and production in response to sucrose feeding and hyperinsulinemia. (1985) (28)
Baseline characteristics of the study population in the Diabetes Atherosclerosis Intervention Study (DAIS). World Health Organization Collaborating Centre for the Study of Atherosclerosis in Diabetes. (1999) (28)
Management of hypertriglyceridemic patients. A. Treatment classifications and goals. (1991) (28)
Atherosclerosis in type 2 diabetes: a role for fibrate therapy? (2007) (27)
Glycation of very low density lipoprotein from rat plasma impairs its catabolism (1990) (27)
Effect of denervation on brown adipose tissue metabolism. (1970) (27)
Triglyceride turnover: a comparison of simultaneous determinations using the radioglyceride and the lipolytic rate procedures. (1975) (27)
Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model. (1998) (27)
Comparison of Type I and Type II Diabetes (1985) (27)
Very-low-density lipoprotein triglyceride kinetics in acute and chronic carbohydrate-fed rats. (1988) (27)
Statement of the problem. (2006) (26)
Insulin Resistance in Obesity as Analyzed by the Response of Glucose Kinetics to Glucagon Infusion (1980) (25)
Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial. (2016) (25)
Dyslipidaemia and coagulation defects of insulin resistance. (2000) (25)
Educating Diabetic Patients (1981) (25)
Normative standards of plasma cholesterol and triglyceride concentrations in Canadians of working age. (1977) (24)
Cold acclimation of hypothyroid rats. (1974) (24)
Lipoprotein lipase in fat-induced hyperlipemia. (1968) (24)
Hyperinsulinaemia and hypertriglyceridaemia. (1994) (22)
Diabetes and atherosclerosis: epidemiology and intervention trials (1994) (22)
Triglyceride-rich lipoprotein metabolism during acute hyperinsulinemia in hypertriglyceridemic humans. (1988) (21)
L-thyroxine in the treatment of obesity without increase in loss of lean body mass. (1973) (21)
Familial hypercholesterolemia: report of coronary death at age 3 in a homozygous child and prenatal diagnosis in a heterozygous sibling. (1982) (21)
Hepatic acetic thiokinase: possible regulatory step in lipogenesis. (1972) (20)
Hepatic acetate levels in relation to altered lipid metabolism. (1973) (20)
Effect of serotonin on brown adipose tissue and on its sympathetic neurons. (1976) (19)
Effect of calcium on [125I]insulin binding to rat adipocytes. (1978) (17)
Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus. (2008) (17)
A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion. (1994) (17)
6 – The Use of Kinetics in Investigating the Metabolism of Very Low and Intermediate-Density Lipoproteins (1982) (17)
Metabolism of the apolipoprotein B-containing lipoproteins. (1986) (17)
Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis. (1974) (16)
4. Acquired (secondary) forms of hypertriglyceridemia (1991) (16)
The dyslipoproteinemias of diabetes. (1994) (16)
Nature of the familial influence on plasma lipid levels. (1979) (15)
FATTY ACID SYNTHESIS AND CONTROL IN BROWN ADIPOSE TISSUE HOMOGENATES (1966) (15)
Brown and white adipose tissue metabolism response to norepinephrine and insulin. (1966) (15)
A new approach to the measurement of glycerol turnover. (1978) (14)
How Can We Improve the Management of Vascular Risk in Type 2 Diabetes: Insights from FIELD (2009) (14)
Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes. (1998) (14)
A new model of human VLDL metabolism based on simultaneous studies of its APOB and triglyceride. (1983) (14)
Comparison of the Efficacy and Safety of Trandolapril and Nifedipine SR in Mild‐to-Moderate Hypertension (1994) (12)
The use of fibrates and of statins in preventing atherosclerosis in diabetes. (2001) (12)
Lipid metabolism: effects of immunosympathectomy and acclimation to cold. (1968) (12)
Insulin resistance and action in hypertriglyceridemia. (1991) (12)
Glutathione peroxidase and glutathione S-transferase activity of platelets (1983) (12)
The effect of chronic insulin delivery via the intraperitoneal versus the subcutaneous route on hepatic triglyceride secretion rate in streptozotocin diabetic rats. (2002) (12)
Diabetes and Atherosclerosis—a Lipoprotein Perspective (1997) (12)
Effect of Acute Hyperinsulinemia on VLDL Triglyceride and VLDL ApoB Production in Normal Weight and Obese Individuals (1993) (11)
Plasma glutathione peroxidase after selenium supplementation in patients with reduced selenium state (1982) (11)
Fractionation of human low density lipoprotein by column chromatography. (1976) (11)
Impact of the Degree of Triglyceridemia (2001) (10)
The use of fibrates and of statins in preventing atherosclerosis in diabetes (2001) (10)
Structural and compositional changes in very low density lipoprotein triacylglycerols during basal lipolysis. (2002) (10)
Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trial evidence. (1996) (10)
Acquired (secondary) forms of hypertriglyceridemia. (1991) (10)
A New Perspective in the Treatment of Dyslipidemia (2005) (9)
Diabetes and atherosclerosis--a lipoprotein perspective. (1997) (8)
Glucose-independent stimulation of lipogenesis by insulin. (1972) (8)
Intermediate-density lipoproteins, diabetes and coronary artery disease. (1998) (7)
A randomized comparative open study of the effects of two oral contraceptives, Triphasil and Ortho 7/7/7, on lipid metabolism. (1993) (7)
Psoriasis, Ichthyosis, and Porphyria (1997) (7)
The need for a different cholesterol lowering drug. (2003) (7)
Very low density lipoprotein binding to adipocytes. (1980) (7)
Heterogeneity of VLDL triglyceride production by the liver and intestine. (1981) (7)
Effects of the 5-HT3 receptor antagonist, ICS 205-930, on oesophageal motor activity and on lower oesophageal sphincter pressure: a double-blind cross-over study. (1990) (6)
In vitro labeling of beta-apolipoprotein with 3H or 14C and preliminary application to turnover studies. (1975) (6)
Failure of chronic hyperinsulinemia to suppress pancreatic glucagon in vivo in the rat. (1991) (6)
Long term open loop intravenous insulin infusion in type I diabetes: feasibility, problems and promise. (1984) (6)
A new method for the fractionation of human plasma high density lipoprotein. (1977) (6)
Very low density lipoprotein binding to cultured aortic endothelium. (1985) (6)
Non-insulin-dependent diabetes mellitus and atherosclerosis: a lipoprotein perspective. (1994) (6)
Milk fat structure of a patient with type 1 hyperlipidemia (1984) (6)
From an excess of fat, diabetics die. (1989) (6)
Appropriate revascularization in stable angina: lessons from the BARI 2D trial. (2014) (6)
An atherosclerosis risk factor assessment program for patients with peripheral arterial occlusive disease. (1988) (5)
Sympathetic ganglia in brown adipose tissue: a new tool to study ganglionic stimulants. (1972) (5)
The effect of low density lipoprotein on in vitro porcine endothelial cell reendothelialization. (1983) (5)
Diabetes mellitus, dyslipoproteinaemias and atherosclerosis (1997) (5)
A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. (1994) (5)
Studies of glucose turnover and renal function in an unusual case of hereditary fructose intolerance. (1977) (5)
Effects of Various Lipid‐Lowering Treatments in Diabetics (1990) (5)
Selenium supplementation: plasma glutathione peroxidase an indicator of selenium intake. (1982) (5)
Comparison of the effect of hyperinsulinemia on acyl-CoA:cholesterol acyltransferase activity in the liver and intestine of the rat. (1994) (4)
Hyperinsulinemia and VLDL kinetics. (1993) (4)
Diabetes and Atherosclerosis (2012) (4)
Glucoregulation in obese man: effects of fasting, glucagon infusion, exercise and diabetes. (1982) (4)
Implications of the global diabetes epidemic (2006) (3)
Diabetes and atherosclerosis. Metabolic links. (1988) (3)
Inhibition of lipogenesis by cylic AMP without altered lipolysis. (1974) (3)
16 – A Model of VLDL Metabolism Based on Its Heterogeneity (1982) (3)
A comparison of the peptide composition of human serum low and very low density lipoprotein. (1975) (3)
Non-insulin-dependent diabetes and atherosclerosis : a lipoprotein perspective (1994) (3)
7. Management of hypertriglyceridemic patients (1991) (2)
An atherosclerosis risk factor assessment program for patients with peripheral arterial occlusive disease (1988) (2)
Acute direct and indirect effects of insulin on hepatic glucose and very low density lipoprotein production (1998) (2)
Production of small HDL particles after intravenous heparin in hypertriglyceridemic (HTG) diabetic and non-diabetic individuals. Studies before and after gemfibrozil therapy (1994) (2)
Lipid lowering in the patients with prediabetes/metabolic syndrome: what is the evidence? (2008) (2)
Remnants and coronary artery disease progression (1994) (2)
Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group. (1994) (2)
Hyperlipidemia, atherosclerosis, and diabetes. (1978) (1)
Clinical trial assessment of lipid-acting drugs in diabetic patients. (1998) (1)
[Research on the effect of noradrenalin on blood sugar, serum potassium and on inorganic serum phosphate in health and in liver disease]. (1956) (1)
Triglyceride-Rich Lipoprotein Metabolism and Diabetes (1995) (1)
Silent ischemia in asymptomatic diabetic patients and its association with autonomic dysfunction and pain threshold (1990) (1)
4.P.210 Apolipoprotein B48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins (1997) (1)
Transfer of newly made triglyceride from hepatocytes to preexisting extracellular very low density lipoproteins. (1987) (1)
Kinetics of VLDL Subfractions (1977) (1)
Effect of hormones and 3', 5'-cyclic AMP on very low density lipoprotein receptors. (1982) (1)
Accuracy Assessment of the Major Constituent Analyzer (2005) (1)
Relationship of glucose intolerance and elevated triglyceride: implications for gemfibrozil (1987) (0)
[Motivation for dental care]. (1990) (0)
Improved Method forQuantitation of B Apoprotein inPlasmaLipoproteins byElectroimmunoassay (1981) (0)
[Effects and side effects of somatostatin]. (1987) (0)
De novo synthesis of lipids in liver and VLDL in the hyperinsulinemic rat during metabolism of perdeuterated ethanol (1994) (0)
Diabetes : Impact of the Degree of Triglyceridemia and Dense LDL in 1 Proatherogenic Role of Elevated CE Transfer From HDL to VLDL (2001) (0)
Organization Section (1976) (0)
2MP01 The role of statin therapy in the prevention of coronary artery disease (CAD) in the diabetic (2003) (0)
George Steiner, Lifetime Achievement Award – 2011: A Clinician Scientist’s Voyage in the Field of Diabetes (2012) (0)
Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha(1)-antitrypsin - Carriers of the Copenhagen City Heart Study - Response (2003) (0)
To Our Readers and Contributors (1958) (0)
Micronized fenofibrate in the management of dyslipidemia. (1998) (0)
Exogenous hyperinsulinemia and kinetics of VLDL-triglyceride in rats. Comparison between intraperitoneal and subcutaneous insulin administration.:Comparison between Intraperitoneal and Subcutaneous Insulin Administration (1989) (0)
Treatment of dyslipoproteinemias in the insulin resistance syndrome (1999) (0)
A question concerning apo B-48: A reply to the letter by P. Avogaro, G.G. Cazzolato and G. Bittolo Bon (Atherosclerosis, 69 (1988( 273) (1988) (0)
Abstract 12072: Predictors of Cardiovascular and Non-Cardiovascular Death: From the Clinic to the Lab (2014) (0)
An approach to measuring the in vivo transformation of glycerol to a very low density lipoprotein triglyceride. (1979) (0)
Iconographies supplémentaires de l'article : Safety and Tolerability of Dalcetrapib (2011) (0)
Diabetes: A Growing CHD Epidemic (2002) (0)
DIABETES AND ATHEROSCLEROSIS: RISK FACTORS AND CLINICAL TRIALS (1998) (0)
W09.200 Insulin resistance is associated with increased VLDL triglyceride and VLDL apoC-III production (2004) (0)
Lipids and lipoproteins in anorexia nervosa before and after partial weight restoration (1994) (0)
Diabetes and Atherosclerosis: The Diabetes Atherosclerosis Intervention Study (Dais) (1996) (0)
THE CARDIOVASCULAR SAFETY OF THE CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR, RO4607381/JTT-705: PHASE II FINDINGS (2008) (0)
Effects of Sucrose Feeding and Hyperinsulinemia on Very Low Density Lipoprotein Particle Size and Production (1986) (0)
4.P.261 Particle size is an important determinant of the fractional catabolic rate of triglyceride-rich human high density lipoproteins in a rabbit model (1997) (0)
0.S.9 Diabetes atherosclerosis intervention study (DAIS) - Baseline characteristics (1997) (0)
We-S15:1 Patient with type 2 diabetes: Main challenges to face the global burden of the disease (2006) (0)
Regulation of in vivo phenylalanine hydroxylation by dietary tyrosine using enrichment in Apo‐B100 (2007) (0)
586 CORONARY DISEASE IN YOUNG CHILDREN: DIAGNOSIS AND SAO INTERVENTION IN 5 ASYMPTOMATIC PATIENTS (PTS) WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HFH) (1985) (0)
第32回日本糖尿病学会総会プログラム・抄録集特別講演II Diabetes and Atherosclerosis: The Role of Insulin and of Triglyceride-rich Lipoproteins (1989) (0)
1SOA03-4 DAIS: New results and links between correcting lipid abnormalities and cardiovascular benefits (2003) (0)
Fenofibrate lowers serum triglycerides and increases low density lipoprotein size in patients with type 2 diabetes (2001) (0)
Diabetes mellitus, dyslipoproteinaemias and atherosclerosis : Macrovascular disease in diabetes (1997) (0)
Cholestyramine tablets, a new option in the treatment of hypercholesterolemia (1994) (0)
ImprovedMethodfor Quantitationof B Apoproteinin PlasmaLipoproteins by Electroimmunoassay (2004) (0)
肝細胞中のトリグリセライド(TG)のVLDLへの転送について (1984) (0)
DAIS: how it relates to other lipid intervention studies in diabetes (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With George A. Steiner?

George A. Steiner is affiliated with the following schools:

University of Toronto

George A. Steiner's Academic­Influence.com Rankings

George A. Steiner's Degrees

Why Is George A. Steiner Influential?

George A. Steiner's Published Works

Published Works

What Schools Are Affiliated With George A. Steiner?

George A. Steiner's AcademicInfluence.com Rankings